TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+2.58%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$107B
AUM Growth
-$263M
(-0.24%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
25.85%
Holding
1,451
New
70
Increased
678
Reduced
517
Closed
90
Top Buys
| 1 |
Apple
AAPL
|
+$328M |
| 2 |
Exxon Mobil
XOM
|
+$206M |
| 3 |
Danaher
DHR
|
+$169M |
| 4 |
Carlisle Companies
CSL
|
+$109M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$108M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$223M |
| 2 |
NVIDIA
NVDA
|
+$184M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$184M |
| 4 |
Accenture
ACN
|
+$137M |
| 5 |
Visa
V
|
+$115M |
Sector Composition
| 1 | Technology | 21.93% |
| 2 | Financials | 18.71% |
| 3 | Healthcare | 11.45% |
| 4 | Industrials | 10.26% |
| 5 | Consumer Discretionary | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Vertex
VERX
$4.14B
| $1.05M | ﹤0.01% |
+29,200
| New | +$1.05M |
|
1152
Middlesex Water
MSEX
$957M
| $1.05M | ﹤0.01% |
20,128
+4,684
| +30% | +$245K |
|
1153
Futu Holdings
FUTU
$26.2B
| $1.04M | ﹤0.01% |
15,884
+498
| +3% | +$32.7K |
|
1154
Noble Corp
NE
$4.75B
| $1.04M | ﹤0.01% |
23,306
-4,020
| -15% | -$179K |
|
1155
Entrada Therapeutics
TRDA
$201M
| $1.02M | ﹤0.01% |
71,308
| – | – |
|
1156
Aurora
AUR
$10.5B
| $1.01M | ﹤0.01% |
365,136
+260,342
| +248% | +$721K |
|
1157
Cabaletta Bio
CABA
$150M
| $1M | ﹤0.01% |
134,030
+7,000
| +6% | +$52.4K |
|
1158
Griffon
GFF
$3.67B
| $990K | ﹤0.01% |
15,500
+6,200
| +67% | +$396K |
|
1159
ICL Group
ICL
$7.87B
| $988K | ﹤0.01% |
228,234
+8,261
| +4% | +$35.8K |
|
1160
Oric Pharmaceuticals
ORIC
$1.02B
| $986K | ﹤0.01% |
139,400
-69,200
| -33% | -$489K |
|
1161
XPO
XPO
$15.4B
| $984K | ﹤0.01% |
+9,268
| New | +$984K |
|
1162
Guardant Health
GH
$7.41B
| $983K | ﹤0.01% |
34,040
-78,884
| -70% | -$2.28M |
|
1163
Photronics
PLAB
$1.34B
| $982K | ﹤0.01% |
39,800
+2,600
| +7% | +$64.1K |
|
1164
Nova
NVMI
$8.11B
| $980K | ﹤0.01% |
4,176
+136
| +3% | +$31.9K |
|
|
VGR
1165
DELISTED
Vector Group Ltd.
VGR
| $977K | ﹤0.01% |
92,400
+24,700
| +36% | +$261K |
|
1166
Immunovant
IMVT
$2.86B
| $972K | ﹤0.01% |
36,800
-32,242
| -47% | -$851K |
|
1167
Tarsus Pharmaceuticals
TARS
$2.4B
| $962K | ﹤0.01% |
35,388
-13,200
| -27% | -$359K |
|
1168
Generation Bio
GBIO
$39.3M
| $961K | ﹤0.01% |
34,069
| – | – |
|
1169
American Woodmark
AMWD
$991M
| $959K | ﹤0.01% |
12,200
+800
| +7% | +$62.9K |
|
1170
Rivian
RIVN
$16.9B
| $953K | ﹤0.01% |
71,032
-96,072
| -57% | -$1.29M |
|
1171
AnaptysBio
ANAB
$619M
| $947K | ﹤0.01% |
37,800
+15,200
| +67% | +$381K |
|
1172
Houlihan Lokey
HLI
$14B
| $944K | ﹤0.01% |
7,000
+4,700
| +204% | +$634K |
|
1173
Alto Neuroscience
ANRO
$105M
| $928K | ﹤0.01% |
+86,792
| New | +$928K |
|
1174
Qualys
QLYS
$4.88B
| $927K | ﹤0.01% |
6,500
+4,200
| +183% | +$599K |
|
1175
Select Medical
SEM
$1.64B
| $926K | ﹤0.01% |
+48,998
| New | +$926K |
|